UNIVERSITY OF MIYAZAKI
Patent Owner
Stats
- 20 US PATENTS IN FORCE
- 3 US APPLICATIONS PENDING
- Feb 15, 2018 most recent publication
Details
- 20 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 163 Total Citation Count
- Oct 20, 2005 Earliest Filing
- 14 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0044,440 BETA-1,3-GLUCAN DERIVATIVE AND METHOD FOR PRODUCING BETA-1,3-GLUCAN DERIVATIVEOct 23, 17Feb 15, 18[C08B]
2017/0282,171 CATALYST PARTICLES, CARBON-SUPPORTED CATALYST PARTICLES AND FUEL CELL CATALYSTS, AND METHODS OF MANUFACTURING SUCH CATALYST PARTICLES AND CARBON-SUPPORTED CATALYST PARTICLESApr 13, 17Oct 05, 17[H01M, B01J]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9629895 Method for prevention or treatment of intractable inflammatory bowel diseaseJan 12, 12Apr 25, 17[A61K]
9598496 Antibody capable of specifically recognizing transferrin receptorMay 07, 12Mar 21, 17[A61K, C07K]
9593165 Antibody capable of specifically recognizing transferrin receptorNov 08, 13Mar 14, 17[C07H, A61K, C12P, C12N, C07K]
9555077 Methods of lowering body temperature by administration of desacyl ghrelin or its derivativeSep 02, 11Jan 31, 17[A61K]
9078868 Therapeutic agent for accelerating recovery of animal under medical treatmentJan 14, 11Jul 14, 15[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0299,339 BETA-1,3-GLUCAN DERIVATIVE AND METHOD FOR PRODUCING BETA-1,3-GLUCAN DERIVATIVEAbandonedNov 14, 13Oct 22, 15[C08B]
2015/0018,225 CELL ADHESION INHIBITOR, CELL PROLIFERATION INHIBITOR, AND METHOD AND KIT FOR EXAMINING CANCERAbandonedMay 11, 12Jan 15, 15[C12N, G01N, C07K]
2013/0236,911 HEMOKININ-1 RECEPTOR AND HEMOKININ-1-DERIVED PEPTIDEAbandonedAug 25, 11Sep 12, 13[C12N, C07K]
2013/0211,059 COMPOSITION SUPPRESSING MATRIX-METALLOPROTEINASE ACTIVITYAbandonedAug 24, 11Aug 15, 13[C07H]
2013/0189,607 CATALYST PARTICLES, CARBON-SUPPORTED CATALYST PARTICLES AND FUEL CELL CATALYSTS, AND METHODS OF MANUFACTURING SUCH CATALYST PARTICLES AND CARBON-SUPPORTED CATALYST PARTICLESAbandonedOct 06, 11Jul 25, 13[H01M]
2013/0096,332 METHOD FOR INCREASING THE CONTENT OF DOCOSAHEXAENOIC ACID IN FAT-CONTAINING MATERIALS OR IN FATS AND OILSAbandonedDec 06, 12Apr 18, 13[C12P]
8349595 Method for increasing the content of docosahexaenoic acid in fat-containing materials or in fats and oilsExpiredJan 25, 08Jan 08, 13[C12P, C12N, C07C]
2012/0100,550 METHOD FOR DETERMINING FATTY ACID SYNTHESIS PATHWAY OF MICROORGANISM, AND PCR PRIMER SET FOR USE IN THE METHODAbandonedMar 04, 10Apr 26, 12[C12Q]
2012/0045,773 CELL ADHESION INHIBITOR AND APPLICATIONS THEREOFAbandonedJan 28, 10Feb 23, 12[C07H, G01N, C07K]
2010/0143,310 SPINAL NERVE REPAIR PROMOTING THERAPEUTICS CONTAINING GHRELIN OR ITS DERIVATIVES OR SUBSTANCES THAT ACT ON GHS-R1a AS AN ACTIVE INGREDIENTAbandonedAug 10, 07Jun 10, 10[A61K, C12N, A61P, C07K]
2009/0305,969 Skin Repair Accelerating Therapeutic Agent Containing Desacyl Ghrelin and Derivatives Thereof as Active IngredientAbandonedNov 21, 06Dec 10, 09[A61K, C12N, A61P]
2009/0181,888 Skin Repair Accelerating Therapeutic Agent Containing Ghrelin and Derivatives Thereof or Substance Acting On GHS-R1a as Active IngredientAbandonedNov 21, 06Jul 16, 09[A61K, C12N, A61P, C07K]
2006/0093,686 Lectin for checking blood type, blood type checking reagent containing the lectin, and method of checking blood type using the blood type checking reagentAbandonedOct 20, 05May 04, 06[A61K, C12Q]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.